EBNEO Commentary: OPTIMIST-ically moving towards targeted noninvasive surfactant therapy?
Acta Paediatr
.
2022 May;111(5):1091-1092.
doi: 10.1111/apa.16261.
Epub 2022 Jan 31.
Authors
Clyde J Wright
1
,
Kirsten Glaser
2
,
Nicolas A Bamat
3
4
Affiliations
1
Section of Neonatology, Department of Pediatrics, Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, Colorado, USA.
2
Division of Neonatology, Department of Women's and Children's Health, University of Leipzig Medical Center, Leipzig, Germany.
3
Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
4
Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
PMID:
35100470
DOI:
10.1111/apa.16261
No abstract available
Publication types
Comment
MeSH terms
Humans
Infant, Newborn
Pulmonary Surfactants* / therapeutic use
Respiratory Distress Syndrome, Newborn* / therapy
Surface-Active Agents / therapeutic use
Substances
Pulmonary Surfactants
Surface-Active Agents